Development of biosimilars in an era of oncologic drug shortages

Development of biosimilars in an era of oncologic drug shortages

Edward Li,1 Janakiraman Subramanian,2 Scott Anderson,3 Dolca Thomas,4 Jason McKinley,5 Ira A Jacobs4 1University of New England College of Pharmacy, Portland, ME, USA; 2Hanna Cancer Associates, Knoxville, TN, USA; 3Pfizer Inc, La Jolla, CA, USA; 4Pfizer Inc, New York, NY,&nbsp...

Full description

Bibliographic Details
Main Authors: Li E, Subramanian J, Anderson S, Thomas D, McKinley J, Jacobs IA
Format: Article
Language:English
Published: Dove Medical Press 2015-06-01
Series:Drug Design, Development and Therapy
Online Access:http://www.dovepress.com/development-of-biosimilars-in-an-era-of-oncologic-drug-shortages-peer-reviewed-article-DDDT

Internet

http://www.dovepress.com/development-of-biosimilars-in-an-era-of-oncologic-drug-shortages-peer-reviewed-article-DDDT

Similar Items